πŸ‡ΊπŸ‡Έ FDA
Patent

US 8629141

Spiro-oxindole MDM2 antagonists

granted A61PA61P35/00A61P35/02

Quick answer

US patent 8629141 (Spiro-oxindole MDM2 antagonists) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P35/00, A61P35/02, A61P43/00